Incorporation of Wholly Owned Step-down Subsidiary in US

September 01, 2026 The General Manager, The Manager, Listing Compliance Department, Listing & Compliance Department Bombay Stock Exchange Limited, The National Stock Exchange of India Limited P.J. Towers, Dalal Street, Exchange Plaza, Bandra Kurla Complex, Mumbai – 400 001 Bandra East, Mumbai - 400051 Company code: 533333 Company code: FCL Subject: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations) – Incorporation of a Wholly Owned Step-down Subsidiary Dear Sir/Madam, Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI Listing Regulations, we wish to inform you that Fineotex Biotex HealthGuard FZE (“FZE Company”), a wholly owned subsidiary of the Company, has incorporated a new wholly-owned step-down subsidiary named Fineotex Holdings Inc. (“FHI”), in USA. The Company has received intimation today, 1st September, 2026 that the Certificate of Incorporation of FHI has been issued by the State of Delaware, USA. In this regard, please find enclosed herewith the disclosure containing details as required under Regulation 30(6) read with clause (1) of Para A of Part A of Schedule III of the SEBI Listing Regulations read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 is enclosed as ‘Annexure - A’. The above information is also available on the website of the Company www.fineotex.com. You are requested to kindly take the above on record. Thanking you, Yours faithfully, For FINEOTEX CHEMICAL LIMITED Sanjay Tibrewala Executive Director DIN: 00218525 Encl: As above Annexure – A SN. Details of Events required to be disclosed Disclosures 1 Name of the target entity, details in brief such as Fineotex Holdings Inc. size, turnover etc. The above company is newly incorporated and therefore the turnover is Nil. 2 Whether the acquisition would fall within related Wholly Owned Subsidiary is a related party of party transaction(s) and whether the promoter/ Fineotex Chemical Limited (‘the Company”) promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at “arm’s length” 3 Industry to which the entity being acquired belongs Specialty Chemicals 4 Objects and impact of acquisition (including but The object of Fineotex Holdings Inc to undertake not limited to, disclosure of reasons for acquisition specialty chemical and allied business activities, of target entity, if its business is outside the main including manufacturing, trading and development line of business of the listed entity) of specialty chemicals, and to pursue strategic investments, acquisitions and other growth opportunities in related or allied businesses. 5 Brief details of any governmental or regulatory Not Applicable approvals required for the acquisition 6 Indicative time period for completion of the Not Applicable acquisition 7 Nature of consideration - whether cash Not Applicable consideration or share swap and details of the same 8 Cost of acquisition or the price at which the shares Not Applicable are acquired 9 Percentage of shareholding/control acquired and/ Fineotex Biotex HealthGuard FZE a wholly owned or number of shares acquired subsidiary of the Company, holds 100% share capital of Fineotex Holdings Inc. 10. Brief background about the entity acquired in terms Fineotex Holdings Inc is newly incorporated in USA of products/line of business acquired, date of and registered with State of Delaware, USA. incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in brief)